Section Arrow
Quote
CVKD.NASDAQ
- Cadrenal Therapeutics Inc
Quotes are at least 15-min delayed:2026/01/07 16:04 EST
After Hours
Last
 7.465
-- (--)
Bid
7.43
Ask
8.96
High 7.465 
Low 7.43 
Volume 113 
Regular Hours (Closed)
Last
 7.46
+0.53 (+7.65%)
Day High 
7.84 
Prev. Close
6.93 
1-M High
12.5 
Volume 
70.25K 
Bid
7.43
Ask
8.96
Day Low
7.125 
Open
7.13 
1-M Low
6.42 
Market Cap 
16.20M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.14 
20-SMA 8.37 
50-SMA 10.23 
52-W High 22.9011 
52-W Low 6.42 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.72/-1.57
Enterprise Value
16.20M
Balance Sheet
Book Value Per Share
1.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1316+0.0266+25.33%-- 
After Hours 0.136 +0.0104 +8.28%
ERASErasca5.425+1.795+49.45%-- 
After Hours 4.49 -0.68 -13.15%
RXRXRecursion Pharmaceuticals4.885+0.335+7.36%-- 
After Hours 4.86 +0.01 +0.21%
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
After Hours 13.73 0 0.00%
GLUEMonte Rosa Therapeutics23.3816+7.3716+46.04%54.09PE
After Hours 22.85 -0.43 -1.85%
Industry overview quotes are at least 15 minutes delayed
Business Description
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.